Biogen shares surged following a report that Samsung is in talks to acquire the US biotech company for more than $40 billion (roughly Rs. 2,98,170 crore).

source https://gadgets.ndtv.com/science/news/samsung-biogen-buy-acquire-deal-talks-aduhelm-neurology-usd-42-billion-2679130#rss-gadgets-all